Literature DB >> 9247089

EPR investigations of the iron domain in neuromelanin.

S Aime1, B Bergamasco, D Biglino, G Digilio, M Fasano, E Giamello, L Lopiano.   

Abstract

The interactions between iron and neuromelanin (NM) have been studied by means of EPR spectroscopy. The variable temperature EPR spectral features of a specimen of NM extracted from normal human midbrains clearly indicate that iron is present as polynuclear oxy-hydroxy ferric aggregates as well as isolated Fe(III) centres. Ferric oxy-hydroxy phases are typical of the iron storage proteins ferritin and hemosiderin, but the comparison of the variable temperature EPR spectra of ferritin and NM highlights significant differences between the two iron(III)oxy-hydroxy domains. Moreover, further investigations on melanin models synthesised in the presence of either ferritin or a ferric salt as iron sources suggest that the same pathway of formation and inclusion of the polynuclear iron oxide is operating in NM and in the model systems, whatever is the source of iron.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247089     DOI: 10.1016/s0925-4439(97)00014-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

Authors:  M Fasano; B Bergamasco; L Lopiano
Journal:  J Neural Transm (Vienna)       Date:  2006-05-12       Impact factor: 3.575

Review 3.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

4.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

Review 5.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

6.  Structure and Function of Iron-Loaded Synthetic Melanin.

Authors:  Yiwen Li; Yijun Xie; Zhao Wang; Nanzhi Zang; Fabio Carniato; Yuran Huang; Christopher M Andolina; Lucas R Parent; Treffly B Ditri; Eric D Walter; Mauro Botta; Jeffrey D Rinehart; Nathan C Gianneschi
Journal:  ACS Nano       Date:  2016-11-01       Impact factor: 15.881

7.  Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Authors:  Emanuele Ferrari; Mireille Engelen; Enrico Monzani; Michela Sturini; Stefania Girotto; Luigi Bubacco; Luigi Zecca; Luigi Casella
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

Review 8.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 9.  Metal imaging in neurodegenerative diseases.

Authors:  Megan W Bourassa; Lisa M Miller
Journal:  Metallomics       Date:  2012-07-16       Impact factor: 4.526

Review 10.  Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models.

Authors:  Andrea Capucciati; Fabio A Zucca; Enrico Monzani; Luigi Zecca; Luigi Casella; Tim Hofer
Journal:  Antioxidants (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.